Analysis of the effects of Tyrosine Kinase Inhibitors Sunitinib and Erlotinib on Serum Metabolism In Vivo using Non-Targeted Metabolomics Analysis

Tags: nihdatacommons NIH Metabolomics Data Repository

URL(s):

View Associations

Digital Object Assessments (2)


Assessment Metrics Date
Rubric Project   NIH program name is available for querying NIH project name is available for querying Machine-readable metadata The institution that created this dataset is available A biological assay is present and resolvable in CFDE-specified ontology (OBI) A relevant anatomical part is present and resolvable in the UBERON Ontology Open, Free, Standardized Access protocol A relevant disease is present and resolvable in the MONDO Ontology A relevant file type is present and resolvable in the EDAM Ontology A relevant taxonomy is present and resolvable in the NCBITaxon Ontology A relevant cell line is present and resolvable in the Cellosaurus Ontology Globally unique identifier Digital resource license Resource identifier in metadata A landing page exists and is accessible Metadata license Contact information is provided for the creator(s) of the dataset.
NIH Common Fund Data Ecosystem (CFDE) FAIR Rubric NIH Common Fund Data Ecosystem (CFDE) FAIR Assessments
no (0.00) yes (1.00) yes (1.00) yesbut (0.75) nobut (0.25) no (0.00) yes (1.00) no (0.00) no (0.00) no (0.00) no (0.00) no (0.00) no (0.00) yesbut (0.75) yes (1.00) yes (1.00) maybe (0.50) Sep 19, 2019
NIH Common Fund Data Ecosystem (CFDE) FAIR Rubric Metabolomics: FAIR Assessment of NIH Common Fund Resources with C2M2
no (0.00) yes (1.00) yes (1.00) yesbut (0.75) nobut (0.25) no (0.00) yes (1.00) no (0.00) no (0.00) no (0.00) no (0.00) no (0.00) no (0.00) yesbut (0.75) yes (1.00) yes (1.00) maybe (0.50) Sep 23, 2019